How resilient is the global biopharma industry?
Pharmaceutical Technology
JULY 29, 2022
As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. Manufacturing agility: Index score 6.5/10. R&D ecosystem - Index score 6.54/10.
Let's personalize your content